A STRATEGICALLY ALIGNED GROUP OF SUBSIDIARY COMPANIES OWNED BY CDA HEALTH PTY LTD
WHO WE ARE
Our journey began back in 2016 with the legislation change to allow medical practitioners to prescribe medical cannabis via the TGA's Special Access Scheme.
A family of progressive professionals, we jumped into action and applied for medical cannabis wholesaling licences.
Our subsidiary Burleigh Heads Cannabis (BHC) was one of the first companies to receive its importing, exporting and wholesaling licences.
Since launching our clinical brand Cannabis Doctors Australia (now known as CDA Clinics) in October 2018, our doctors have been approved by the TGA to prescribe over 8000 patients.
Via BHC's CanView platform, we've provided products to almost 30% of the Australian medical cannabis market.
WE'RE A DOCTOR LED GROUP OF COMPANIES THAT IS FOCUSED TO PROVIDE HIGH QUALITY SERVICE AND CANNABIS PRODUCTS TO DOCTORS AND PHARMACISTS AND THEIR PATIENTS WITH CHRONIC CONDITIONS
In May 2019, for the first time in Australia, both retail and sophisticated investors had the chance to buy shares in CDA Health. This crowdfunding share offer successfully met its target and has now closed.
This funding from everyday investors has allowed CDA health to expand to:
Updated August 2021
For existing Investors:
Thank you for your ongoing support.
Please refer to your email from Cake Equity to activate your account. Within the platform you can access your investment documents and receive updates.
If you haven't received your invitation or you have any other investor related questions please email email@example.com
OUR PROVEN SUCCESS GIVES US CONFIDENCE TO EXPAND INTO CLINICAL RESEARCH, DATA MINING,TECHNOLOGY, MANUFACTURING, AND POSSIBLY CULTIVATION.